Table 4.
Characteristic | OR (95% CI) | P |
---|---|---|
Diagnosis (CD) | 0.74 (0.62-0.88) | 0.006 |
Age | 0.99 (0.99-1.01) | 0.75 |
Female gender | 0.76 (0.63-0.91) | 0.003 |
Disease duration | 1.01 (0.99-1.02) | 0.31 |
CRP | 1.37 (1.26-1.49) | <0.0001 |
ESR | 1.03 (1.02-1.04) | <0.0001 |
HBI | 1.07 (1.04-1.10) | <0.0001 |
UCAI | 1.07 (1.04-1.10) | <0.0001 |
Use of immunomodulators | 1.51 (1.24-1.82) | <0.0001 |
Use of biologics | 2.00(1.58-2.52) | <0.0001 |
Surgery for IBD | 2.77 (2.28-3.35) | <0.0001 |
OD, odds ratio; CI, confidence interval; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IBD, inflammatory bowel disease; HBI, Harvey-Bradshaw index; UCAI, ulcerative colitis activity index